Journal
SCIENCE
Volume 291, Issue 5511, Pages 2150-2155Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1058308
Keywords
-
Categories
Funding
- NIAID NIH HHS [R01-AI-48540-01] Funding Source: Medline
Ask authors/readers for more resources
The activation of gp130, a shared signal-transducing receptor for a family of cytokines, is initiated by recognition of Ligand followed by oligomerization into a higher order signaling complex. Kaposi's sarcoma-associated herpesvirus encodes a functional homolog of human interleukin-6 (IL-6) that activates human gp130. In the 2.4 angstrom crystal structure of the extracellular signaling assembly between viral IL-6 and human gp130, two complexes are cross-linked into a tetramer through direct interactions between the immunoglobulin domain of gp130 and site III of viral IL-6, which is necessary for receptor activation. Unlike human IL-6 (which uses many hydrophilic residues), the viral cytokine Largely uses hydrophobic amino acids to contact gp 130, which enhances the complementarity of the viral IL-6-gp130 binding interfaces. The cross-reactivity of gp130 is apparently due to a chemical plasticity evident in the amphipathic gp130 cytokine-binding sites.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available